trending Market Intelligence /marketintelligence/en/news-insights/trending/6vsc9qd-f_izybu_il-inq2 content esgSubNav
In This List

Zoetis-Abaxis deal receives antitrust clearance

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Zoetis-Abaxis deal receives antitrust clearance

Zoetis Inc. said its previously announced acquisition of Abaxis Inc. received antitrust clearance under the Hart-Scott-Rodino Act.

The transaction is subject to other customary closing conditions, including approval from Abaxis shareholders, who will vote on the deal at a July 31 special meeting.

The Parsippany, N.J.-based animal health company said it expects to close the deal shortly after the Abaxis meeting. Zoetis added that it plans to pay for the acquisition through existing cash and new debt.

Union City, Calif.-based Abaxis makes and sells portable blood analysis systems for use in human or veterinary patient care.